期刊文献+

前列腺特异抗原移行区密度在PSA灰色区域前列腺癌早期诊断中的作用 被引量:3

The Value of PSA density of transition zone on early diagnosis of Prostate cancer
下载PDF
导出
摘要 目的探讨前列腺特异抗原移行区密度(PSAT)在前列腺癌早期诊断中的作用。方法在血清PSA>4.0 ng/ml,并接受前列腺活检的144例受检者为研究对象,根椐病理学诊断分为前列腺癌组(PCa组)、良性前列腺增生组(BPH组);血清PSA含量应用瑞典CanAG公司试剂盒;经直肠超声测量前列腺癌体积和移行区体积,分别计算前列腺特异抗原密度(PASD)和PSAT。应用SPSS(10.0)软件进行统计学分析。结果(1)受检者的前列腺移行区体积与前列腺总体积呈明显正相关(r=0.78,P<0.001)。(2)BPH组与PCa组比校,总体积无显著差别(P>0.05),前列腺移行区体积、PSA、PSADP、SAT均有显著差别。ROC曲线显示PSAT的曲线下面积(AUC)为0.771大于PSA、PSAD,且有显著差别(P<0.01)。(3)在灰色区域,PSAT在BPH组和PCa组中存在显著差别;ROC曲线表明PSAT强于PSAD。结论前列腺特异抗原移行区密度是提高前列腺癌早期诊断效率的有效指标。 Objective To stduy the value of prostate specific antigen of transition zone (PSAT), on early diagnosis of prostate can- cer.Methods During the prostate cancer screening, 144patients were selected into the research with the pathological stages;and were divided PCa group and BPH group.The serum PSA was measured with CanAg PSA kit;and the patients'prostate total volume,transition zone volume (TZ) were recorded,PSAT were calculated with the formula: PSAT = PSA/TZ.All the data manage with SPSS10.Results The result showed that ( 1)Between BPH and PCa group,prostate total volume ( r = 0.78, P 〈 0.001). (2)Between BPHand PCa group, prostate total volume has no significance ( P 〉 0.05), TZ, PSA, PSAT, PSAD, all has significance ( P 〈 0.05 ). ROC Curves revealed PSAT has better sensitivity and specificity on detecting prostate cancer (AUC for PSAT:0.771). (3)In the grey zone,PSAT was more significance than PSAD between BPH group and PCa group. Conclusion PSAT is better diagnosis marker in early diagnosis in prostate
出处 《中国实验诊断学》 2007年第10期1353-1355,共3页 Chinese Journal of Laboratory Diagnosis
基金 国家科技部 中日政府间专项枝术合作项目 第59项
关键词 PSAT 前列腺癌 早期诊断 Prostate specific antigen of transition zone (PSAT) prostate cancer diagnosis
  • 相关文献

参考文献2

二级参考文献16

  • 1Humphrey PA, Vollmer RT. Relationships between serum proslate-specific antigen and histopathologic appearances of prostate carcinoma. In: Foster CS, Bostwick DG, editors. Pathology of Prostate. London: W. B. Saunders Company; 1998.p253-81.
  • 2Harada M, Nemoto R, Uchida K, Akaza H, Koiso K, Mostofi FK. Histopathological comparison of prostatic adenocarcinoma in Japan and the United States. Nippon Hinyokika Gakkai Zasshi 1993; 84:1110-18.
  • 3Humphrey PA, Keetch DW, Smith DS, Shepherd DL, Catalona WJ. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. J Urol 1996; 155: 816-20.
  • 4Bostick DG, Dundore P. Biopsy Pathology of the Prostate.New York: Chapman & Hall Medical; 1997. p141-63.
  • 5Rigley JR, Bullock M, Amin M. Small glandular patterns in the prostate: differential diagnosis of small acinar carcinoma.In: Foster CS, Bostwick DG, editors. Pathology of Prostate.London: W. B. Saunders Company; 1998. p126-55.
  • 6Shirley SE, Escoffery CT, Sargeant LA, Tulloch T. Clinicopathological features of prostate cancer in Jamaican men. BJU Int 2002; 89: 390-5.
  • 7Catalona W J, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151: 1283-90.
  • 8Hoedemaeker RF, van der Kwast TH, Boer R, de Koning HJ,Roobol M, Vis AN, et al. Pathologic features of prostate cancer found at population-based screening with a four-year interval. J Natl Cancer Inst 2001; 93:1153-8.
  • 9JosephE,OesterlingM,MoyadA.TheABCsofProstateCancer[]..1997
  • 10MettlinC,MurphyG P,RichardJ ,etal.Theresultsofafive yearearlyprostatecancerdetectionintervention[].Cancer.1996

共引文献45

同被引文献34

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部